论文部分内容阅读
目的:探讨促性腺激素释放激素激动剂(GnRHa)治疗子宫内膜异位症(Ems)的不良反应。方法:选取该院2009年1月～2011年2月入院治疗的72例Ems患者为研究对象,随机分为治疗组36例,对照组96例,针对两组不同治疗方法的效果以及相关的不良反应进行比较分析。结果:两组患者实施不同治疗后,在整体治疗效果方面,组间比较,治疗组整体效果优于对照组,且均P<0.05,差异具有统计学意义;在不良反应方面,组间比较,治疗组整体优于对照组,且均P<0.05,差异具有统计学意义。结论:在临床治疗Ems的过程中,采用GnRHa的治疗效果显著,是临床治疗Ems的可靠选择。
Objective: To investigate the adverse reactions of gonadotropin-releasing hormone agonist (GnRHa) for endometriosis (Ems). Methods: Seventy-two patients with Ems hospitalized from January 2009 to February 2011 in our hospital were selected and randomly divided into treatment group (36 cases) and control group (96 cases). According to the results of two groups of different treatment methods and their related problems The reaction was analyzed comparatively. Results: In the two groups of patients after the implementation of different treatment, the overall effect of treatment, compared between the two groups, the overall effect of the treatment group is better than the control group, and P <0.05, the difference was statistically significant; adverse reactions, The treatment group overall better than the control group, and were P <0.05, the difference was statistically significant. Conclusion: In the clinical treatment of Ems, the treatment with GnRHa is effective and is a reliable choice for clinical treatment of Ems.